Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...

Novavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Plus, options traders eye NVAX; CMI surges to fresh peak; and CE looks to extend losing streak.

While it is too early to know how this season’s flu will play out, we do know that COVID-19 is still with us.’ ...

Vaccine production is nearly three years behind schedule at a federally owned plant in Montreal and the future of a deal ...

The vaccine helps to prevent bacterial infections that can cause serious illness in older adults, such as pneumonia.

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...